Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


13.11.2017

3 Am J Hematol
1 Ann Hematol
2 Blood
1 Br J Cancer
2 Cancer
1 Cancer Chemother Pharmacol
2 Cancer Res
2 Eur J Haematol
1 Exp Hematol
1 J Virol
2 Leuk Lymphoma
3 Leuk Res
1 Leukemia
4 N Engl J Med
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Hematol

  1. DEANGELO DJ, Brunner AM, Werner L, Avigan D, et al
    A Phase I Study of Lenalidomide plus Chemotherapy with Mitoxantrone, Etoposide, and Cytarabine for the Reinduction of Patients with Acute Myeloid Leukemia.
    Am J Hematol. 2017 Nov 9. doi: 10.1002/ajh.24968.
    PubMed     Text format     Abstract available

  2. CANAANI J, Savani BN, Labopin M, Huang XJ, et al
    Donor age determines outcome in acute leukemia patients over 40 undergoing haploidentical hematopoietic cell transplantation.
    Am J Hematol. 2017 Nov 8. doi: 10.1002/ajh.24963.
    PubMed     Text format     Abstract available

  3. TROUSSARD X, Cornet E
    Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment.
    Am J Hematol. 2017;92:1382-1390.
    PubMed     Text format     Abstract available


    Ann Hematol

  4. SHAO H, Yang Q, Zhang P, Liu H, et al
    Simultaneous occurrence of two distinct leukemic clones with PML-RARalpha and RUNX1-RUNX1T1 in a case of acute myeloid leukemia.
    Ann Hematol. 2017 Nov 9. doi: 10.1007/s00277-017-3169.
    PubMed     Text format    


    Blood

  5. QUESADA AE, Konoplev S
    Classical Hodgkin lymphoma arising in a patient with chronic lymphocytic leukemia (Richter syndrome).
    Blood. 2017;130:2151.
    PubMed     Text format    

  6. HU Z, Konoplev S
    Aleukemic mast cell leukemia associated with chronic myelomonocytic leukemia and chronic lymphocytic leukemia.
    Blood. 2017;130:2150.
    PubMed     Text format    


    Br J Cancer

  7. BINDELS LB, Porporato PE, Ducastel S, Sboarina M, et al
    Ffar2 expression regulates leukaemic cell growth in vivo.
    Br J Cancer. 2017;117:1336-1340.
    PubMed     Text format     Abstract available


    Cancer

  8. GOLDSBY RE, Stratton KL, Raber S, Ablin A, et al
    Long-term sequelae in survivors of childhood leukemia with Down syndrome: A childhood cancer survivor study report.
    Cancer. 2017 Nov 3. doi: 10.1002/cncr.31065.
    PubMed     Text format     Abstract available

  9. ZHENG DJ, Lu X, Schore RJ, Balsamo L, et al
    Longitudinal analysis of quality of life outcomes in children during treatment for acute lymphoblastic leukemia: A report from the Children's Oncology Group AALL0932 trial.
    Cancer. 2017 Nov 7. doi: 10.1002/cncr.31085.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  10. EMADI A, Law JY, Strovel ET, Lapidus RG, et al
    Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemia.
    Cancer Chemother Pharmacol. 2017 Nov 8. doi: 10.1007/s00280-017-3459.
    PubMed     Text format     Abstract available


    Cancer Res

  11. LE SOMMER S, Morrice N, Pesaresi M, Thompson D, et al
    Deficiency in protein tyrosine phosphatase PTP1B shortens lifespan and leads to development of acute leukemia.
    Cancer Res. 2017 Nov 9. pii: canres.0946.2017.
    PubMed     Text format     Abstract available

  12. BRUNER JK, Ma HS, Li L, Qin ACR, et al
    Adaptation to TKI Treatment Reactivates ERK Signaling in Tyrosine Kinase-Driven Leukemias and Other Malignancies.
    Cancer Res. 2017;77:5554-5563.
    PubMed     Text format     Abstract available


    Eur J Haematol

  13. LENGFELDER E, Gorlich D, Nowak D, Spiekermann K, et al
    Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines.
    Eur J Haematol. 2017 Nov 7. doi: 10.1111/ejh.12994.
    PubMed     Text format     Abstract available

  14. COMBARIZA JF, Toro LF, Orozco JJ, Arango M, et al
    Cost-effectiveness analysis of interventions for prevention of invasive aspergillosis among leukemia patients during hospital construction activities.
    Eur J Haematol. 2017 Nov 6. doi: 10.1111/ejh.12991.
    PubMed     Text format     Abstract available


    Exp Hematol

  15. BOILA LD, Chatterjee SS, Banerjee D, Sengupta A, et al
    KDM6 and KDM4 histone lysine demethylases emerge as molecular therapeutic targets in human acute myeloid leukemia.
    Exp Hematol. 2017 Oct 27. pii: S0301-472X(17)30824.
    PubMed     Text format     Abstract available


    J Virol

  16. BAMUNUSINGHE D, Liu Q, Plishka R, Dolan MA, et al
    Recombinant Origins of Pathogenic and Nonpathogenic Mouse Gammaretroviruses with Polytropic Host Range.
    J Virol. 2017;91.
    PubMed     Text format     Abstract available


    Leuk Lymphoma

  17. AYED AO, Parikh SA
    Management of patients with chronic lymphocytic leukemia at high risk of relapse on ibrutinib therapy.
    Leuk Lymphoma. 2017 Nov 8:1-10. doi: 10.1080/10428194.2017.1397665.
    PubMed     Text format     Abstract available

  18. MARTINEZ-TRILLOS A, Pinyol M, Delgado J, Aymerich M, et al
    The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia.
    Leuk Lymphoma. 2017 Nov 8:1-9. doi: 10.1080/10428194.2017.1397660.
    PubMed     Text format     Abstract available


    Leuk Res

  19. NACHAR VR, Perissinotti AJ, Scappaticci GB, Bixby DL, et al
    Predictors for requiring re-induction chemotherapy in acute myeloid leukemia patients with residual disease on day 14 bone marrow assessment.
    Leuk Res. 2017;63:56-61.
    PubMed     Text format     Abstract available

  20. OZDOGAN H, Gur Dedeoglu B, Oztemur Islakoglu Y, Aydos A, et al
    DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Leuk Res. 2017;63:62-71.
    PubMed     Text format     Abstract available

  21. NOMDEDEU M, Pereira A, Calvo X, Colomer J, et al
    Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS Group.
    Leuk Res. 2017;63:85-89.
    PubMed     Text format     Abstract available


    Leukemia

  22. NIMMAGADDA SC, Frey S, Edelmann B, Hellmich C, et al
    Bruton's Tyrosine Kinase and RAC1 promote cell survival in MLL-rearranged acute myeloid leukemia.
    Leukemia. 2017 Nov 7. doi: 10.1038/leu.2017.
    PubMed     Text format     Abstract available


    N Engl J Med

  23. ROSENBAUM L
    Tragedy, Perseverance, and Chance - The Story of CAR-T Therapy.
    N Engl J Med. 2017;377:1313-1315.
    PubMed     Text format    


  24. Midostaurin in FLT3-Mutated Acute Myeloid Leukemia.
    N Engl J Med. 2017;377:1902.
    PubMed     Text format    

  25. ESKAZAN AE
    Midostaurin in FLT3-Mutated Acute Myeloid Leukemia.
    N Engl J Med. 2017;377:1901.
    PubMed     Text format    

  26. SAHOO RK, Kumar L
    Midostaurin in FLT3-Mutated Acute Myeloid Leukemia.
    N Engl J Med. 2017;377:1901-2.
    PubMed     Text format    


    PLoS One

  27. CHABER R, Gurgul A, Wrobel G, Haus O, et al
    Whole-genome DNA methylation characteristics in pediatric precursor B cell acute lymphoblastic leukemia (BCP ALL).
    PLoS One. 2017;12:e0187422.
    PubMed     Text format     Abstract available

  28. MIN H, Niu M, Zhang W, Yan J, et al
    Emodin reverses leukemia multidrug resistance by competitive inhibition and downregulation of P-glycoprotein.
    PLoS One. 2017;12:e0187971.
    PubMed     Text format     Abstract available

  29. DUCHARTRE Y, Bachl S, Kim HN, Gang EJ, et al
    Effects of CD49d-targeted antisense-oligonucleotide on alpha4 integrin expression and function of acute lymphoblastic leukemia cells: Results of in vitro and in vivo studies.
    PLoS One. 2017;12:e0187684.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: